Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

PetMed Express Q4 Profit Slips

RELATED NEWS
Trade PETS now with 

PetMed Express Inc. (PETS: Quote) Monday reported a decline in profit for the fourth quarter, as higher operating expenses offset a double-digit revenue growth.

The Pompano Beach, Florida-based company's fourth-quarter net profit was $3.99 million, compared to $4.15 million last year. On a per-share basis, earnings rose to $0.20 from $0.19, due mainly lower shares count. On average, seven analysts polled by Thomson Reuters expected the company to earn $0.18 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter grew 10 percent to $55.92 million from $50.91 million in the prior-year quarter. Five analysts had a consensus revenue estimate of $52.05 million for the quarter.

For the quarter, total operating expenses increased to $12.69 million from $11.03 million in the similar quarter last year.

Click here to receive FREE breaking news email alerts for PetMed Express Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks continue to show a lack of direction in mid-day trading on Tuesday following the long, holiday weekend. Even with the lackluster performance, the markets are largely holding on to the bulk of their recent gains. After reporting an unexpected drop in U.S. construction spending in the previous month, the Commerce Department released a report on Tuesday showing that construction spending rebounded by more than expected in the month of July. Activity in the U.S. manufacturing sector unexpectedly grew at an accelerated rate in the month of August, according to a report released by the Institute for Supply Management on Tuesday, with the index of activity in the sector climbing to a three-year high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.